University of Minnesota. Driven to Discover.
California and Washington state report their first cases, as CDC experts advise on what doctors should be alert for.
The agency also alerts clinicians about COVID-19 rebound after Paxlovid.
COVID-19 patients had persistent signs of heart and lung involvement, inflammation, and clotting.
FDA advisers will meet in a few weeks to discuss emergency use of 3 doses.
Compared with Omicron, MIS-C rate was 14 times higher amid Alpha and 13 times higher during Delta.
A plant closing could affect 5 essential generic drugs for which Teva had an over 15% market share.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2022 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.